ListarGrupo de investigación cardiovascular (GRINCAR) por tema "Cardiac biomakers"
Mostrando ítems 1-1 de 1
-
Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors
(Elsevier, 2023-04-18)[Abstract] Introduction. Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data on longitudinal studies about early and late onset cardiotoxicity in this ...